Nanobiotechnology and Nanomedicine Companies
Showing results 1 - 10 of 11 of companies in UK:
Provides labelled and chemically modified oligonucleotide scaffolds for nanotechnology applications.
BBI Solutions has served the global diagnostics industry for over 50 years, as a leading developer and manufacturer of raw materials and finished test platforms for the in-vitro diagnostics market.
Endomagnetics was founded to solve healthcare challenges through the application of advanced magnetic sensing technology.
Inanovate creates nano-scale surface structures through a unique and proprietary process capable of nano-meter precision in a time and cost effective way. Leveraging this unique platform and expertise, Inanovate is developing nano-structured biochip substrates to facilitate the next generation in biochip technology.
The company specializes in providing protein engineering to pharmaceutical and biotechnology companies for the discovery, identification and design of new peptide, polypeptide, protein and antibody compounds using their proprietary technology.
Design, synthesis and manufacture of biocompatible nanoparticles called nanocells.
nanoTherics Ltd was formed in August 2007 to exploit a novel gene transfection technology arising from biomedical research at Keele University and the University of Florida. The patented technology uses nanoparticles and magnetic fields to facilitate the delivery of foreign DNA into living cells.
Oxford Nanopore Technologies Ltd is developing nanopore technology, a revolutionary method of molecular detection and analysis with potential applications in DNA sequencing, diagnostics, drug development and defence.
Randox Food Diagnostics is a division of Randox Laboratories who have 30 years experience in the diagnostic market and a devoted research and development team. Randox Food Diagnostics is a dedicated company responsible for the distribution of Randox drug residue kits, wine testing kits and analysers worldwide. Randox Food Diagnostics incorporate several market related products dedicated to the food, wine and beverage industries. Randox uses in house developed antibodies and conjugates for a wide range of their screening products including the patented Biochip Array Technology (multiplex screening platform).
The company has developed synthetic, nanostructured bone graft substitutes that will revolutionize the treatment of bone defects and fusions.